PRESS RELEASE published on 05/14/2025 at 07:30, 10 months 15 days ago Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF published on 04/30/2025 at 07:35, 10 months 29 days ago Nicox Reports Full Year 2024 Financials Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
PRESS RELEASE published on 04/30/2025 at 07:30, 10 months 29 days ago Nicox Provides Full Year 2024 Financial Results Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025 Financial Results Revenue Nicox NCX 470 VYZULTA
BRIEF published on 03/19/2025 at 07:35, 1 year ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF published on 01/28/2025 at 07:35, 1 year 2 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 2 months ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 2 months ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year 2 months ago Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Nicox provides Q4 2024 financial highlights, including €13.7 million revenue and €10.7 million cash. Final patient enrolled in NCX 470 trial, with results expected in Q3 2025 Financial Highlights Nicox Q4 2024 Q3 2025 NCX 470 Trial
Published on 03/29/2026 at 12:15, 4 hours 29 minutes ago China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 14 hours ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 14 hours ago Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:45, 1 day 16 hours ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 10:05, 1 day 6 hours ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 7 hours ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 14 hours ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 17 hours ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 1 day 19 hours ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 18:52, 1 day 20 hours ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 1 day 21 hours ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 1 day 21 hours ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 1 day 21 hours ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
